￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

ophthalmology

Lytenava: The First FDA-Approved Ophthalmic Bevacizumab Formulation

2026-07-29 06:08:41

Lytenava (bevacizumab-vikg) is the first ophthalmic bevacizumab formulation approved by the FDA, developed by Outlook Therapeutics for the treatment of wet age-related macular degeneration (wet AMD). It received FDA approval on July 24, 2026.

Check Details
The latest price list of eye drops for the treatment of senile cataract

2025-10-19 11:44:20

Check Details
List of new purchase methods for elderly cataract treatment eye drops

2025-10-19 11:44:20

Check Details
Price List of Eye Drops for Senile Cataract Treatment

2025-10-19 11:44:20

Check Details
Is there a suitable way to purchase authentic eye drops for elderly cataract treatment?

2025-10-19 11:44:20

Check Details
The latest price of senile cataract treatment eye drops in 2025 published on the entire network

2025-10-19 11:44:20

Check Details
Where can I buy eye drops for senile cataract treatment more reliably?

2025-10-19 11:44:20

Check Details
Vuity eye drops latest price list

2025-10-19 11:44:20

Check Details
List of new purchasing methods for Vuity Eye Drops

2025-10-19 11:44:20

Check Details
Vuity eye drops price list

2025-10-19 11:44:20

Check Details
Is there a suitable way to purchase genuine Vuity eye drops?

2025-10-19 11:44:20

Check Details
The latest price of Vuity eye drops in 2025 published on the whole network

2025-10-19 11:44:20

Check Details
Category
相关知识